Oncology Research

A Novel Immunodeficient Rat for Modeling Human Cancer

A Novel Immunodeficient Rat for Modeling Human Cancer

Hera Admin2022-10-12T13:34:43+00:00

Novel immunodeficient rat models capable of supporting the growth of human tumor xenografts

Novel immunodeficient rat models capable of supporting the growth of human tumor xenografts

Hera Admin2022-10-12T13:34:43+00:00

Novel immunodeficient rat models offers a unique platform for drug efficacy studies in human tumor xenografts

Novel immunodeficient rat models offers a unique platform for drug efficacy studies in human tumor xenografts

Hera Admin2022-10-12T13:34:43+00:00

Frequently Asked Questions about the SRG^™ Rat

What is the SRG Rat? A genetically modified novel rat [...]

Jack Crawford2022-11-17T17:19:10+00:00

OncoRat Validated Tumor Models

OncoRat® Validated Tumor Models The [...]

Hera Admin2023-07-31T15:04:35+00:00

OncoRat SRG – Outperforming The Mouse For Xenografts

Jack Crawford2022-10-07T08:34:49+00:00

Improving Preclinical Anticancer Studies Using Rat Xenograft Model Systems

Jack Crawford2022-09-30T15:45:38+00:00

SRG™ Rat (OncoRat^®) Enables Precision Medicine-Based Cancer Studies

SRG™ Rat (OncoRat^®) Enables Precision Medicine-Based Cancer Studies

Follow as our Grace Walton, PhD reviews validation results from [...]

Jack Crawford2022-10-07T08:36:31+00:00

Cell Line Development

Cell Line Development

Jack Crawford2022-10-07T19:43:44+00:00

Acute Myeloid Leukemia MOLM13 And Optimus

Insightful Insights, IVO

Acute Myeloid Leukemia MOLM13 And Optimus

The American Cancer Society estimates that approximately 60,650 new leukemia [...]

Hera Admin2022-05-18T17:37:50+00:00

Previous 567 Next

Title